Get the Stockscreener App
89.28
2.89%
-2.655
Why is Lantheus Holdings Inc (LNTH) Stock down?
We've noticed a 6.33% decline in Lantheus Holdings Inc (LNTH) stock during the 2024-11-13 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
18 Dec, 2023:
Shares of Lantheus Holdings Inc (LNTH) dropped by 26.88% from $76.04 to $55.60 in the trading on Monday, December 18, 2023. The reason why LNTH down today is due to the release of new data from a trial of the experimental prostate cancer treatment, Lu-PNT2002, developed by Lantheus Holdings and Point Biopharma Global Inc. The therapy achieved its primary goal with a median progression-free survival of 9.5 months, compared to six months for an alternative treatment. However, investors were disappointed as Novartis AG's Pluvicto, a similar radioligand therapy, showed better results with a median progression-free survival of 12 months in October.
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):